COVID-19 Impact on Global Prophylactic Human Vaccine, Market Insights and Forecast to 2026
Prophylactic Human Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prophylactic Human Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Prophylactic Human Vaccine market is segmented into
The Prophylactic Human Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Prophylactic Human Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Prophylactic Human Vaccine Market Share Analysis
Prophylactic Human Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prophylactic Human Vaccine business, the date to enter into the Prophylactic Human Vaccine market, Prophylactic Human Vaccine product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Prophylactic Human Vaccine market is segmented into
- Inactivated Vaccine
- Attenuated Vaccine
- Others
- Hospital
- Scientific Research
- Others
The Prophylactic Human Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Prophylactic Human Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Prophylactic Human Vaccine Market Share Analysis
Prophylactic Human Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prophylactic Human Vaccine business, the date to enter into the Prophylactic Human Vaccine market, Prophylactic Human Vaccine product introduction, recent developments, etc.
The major vendors covered:
- GSK
- Biovac
- McKesson Medical
- Merck
- Merial
- Zoetis
- Sanofi
1 STUDY COVERAGE
1.1 Prophylactic Human Vaccine Product Introduction
1.2 Market Segments
1.3 Key Prophylactic Human Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Prophylactic Human Vaccine Market Size Growth Rate by Type
1.4.2 Inactivated Vaccine
1.4.3 Attenuated Vaccine
1.4.4 Others
1.5 Market by Application
1.5.1 Global Prophylactic Human Vaccine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Scientific Research
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Prophylactic Human Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Prophylactic Human Vaccine Industry
1.6.1.1 Prophylactic Human Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Prophylactic Human Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Prophylactic Human Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Prophylactic Human Vaccine Market Size Estimates and Forecasts
2.1.1 Global Prophylactic Human Vaccine Revenue 2015-2026
2.1.2 Global Prophylactic Human Vaccine Sales 2015-2026
2.2 Prophylactic Human Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Prophylactic Human Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Prophylactic Human Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PROPHYLACTIC HUMAN VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Prophylactic Human Vaccine Sales by Manufacturers
3.1.1 Prophylactic Human Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Prophylactic Human Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Prophylactic Human Vaccine Revenue by Manufacturers
3.2.1 Prophylactic Human Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Prophylactic Human Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Prophylactic Human Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Prophylactic Human Vaccine Revenue in 2019
3.2.5 Global Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Prophylactic Human Vaccine Price by Manufacturers
3.4 Prophylactic Human Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Prophylactic Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prophylactic Human Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Prophylactic Human Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Prophylactic Human Vaccine Market Size by Type (2015-2020)
4.1.1 Global Prophylactic Human Vaccine Sales by Type (2015-2020)
4.1.2 Global Prophylactic Human Vaccine Revenue by Type (2015-2020)
4.1.3 Prophylactic Human Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Prophylactic Human Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Prophylactic Human Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Prophylactic Human Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Prophylactic Human Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Prophylactic Human Vaccine Market Size by Application (2015-2020)
5.1.1 Global Prophylactic Human Vaccine Sales by Application (2015-2020)
5.1.2 Global Prophylactic Human Vaccine Revenue by Application (2015-2020)
5.1.3 Prophylactic Human Vaccine Price by Application (2015-2020)
5.2 Prophylactic Human Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Prophylactic Human Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Prophylactic Human Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Prophylactic Human Vaccine by Country
6.1.1 North America Prophylactic Human Vaccine Sales by Country
6.1.2 North America Prophylactic Human Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Prophylactic Human Vaccine Market Facts & Figures by Type
6.3 North America Prophylactic Human Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Prophylactic Human Vaccine by Country
7.1.1 Europe Prophylactic Human Vaccine Sales by Country
7.1.2 Europe Prophylactic Human Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Prophylactic Human Vaccine Market Facts & Figures by Type
7.3 Europe Prophylactic Human Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Prophylactic Human Vaccine by Region
8.1.1 Asia Pacific Prophylactic Human Vaccine Sales by Region
8.1.2 Asia Pacific Prophylactic Human Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Prophylactic Human Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Prophylactic Human Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Prophylactic Human Vaccine by Country
9.1.1 Latin America Prophylactic Human Vaccine Sales by Country
9.1.2 Latin America Prophylactic Human Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Prophylactic Human Vaccine Market Facts & Figures by Type
9.3 Central & South America Prophylactic Human Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Prophylactic Human Vaccine by Country
10.1.1 Middle East and Africa Prophylactic Human Vaccine Sales by Country
10.1.2 Middle East and Africa Prophylactic Human Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Prophylactic Human Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Prophylactic Human Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description, Business Overview and Total Revenue
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Prophylactic Human Vaccine Products Offered
11.1.5 GSK Recent Development
11.2 Biovac
11.2.1 Biovac Corporation Information
11.2.2 Biovac Description, Business Overview and Total Revenue
11.2.3 Biovac Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biovac Prophylactic Human Vaccine Products Offered
11.2.5 Biovac Recent Development
11.3 McKesson Medical
11.3.1 McKesson Medical Corporation Information
11.3.2 McKesson Medical Description, Business Overview and Total Revenue
11.3.3 McKesson Medical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 McKesson Medical Prophylactic Human Vaccine Products Offered
11.3.5 McKesson Medical Recent Development
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description, Business Overview and Total Revenue
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Prophylactic Human Vaccine Products Offered
11.4.5 Merck Recent Development
11.5 Merial
11.5.1 Merial Corporation Information
11.5.2 Merial Description, Business Overview and Total Revenue
11.5.3 Merial Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merial Prophylactic Human Vaccine Products Offered
11.5.5 Merial Recent Development
11.6 Zoetis
11.6.1 Zoetis Corporation Information
11.6.2 Zoetis Description, Business Overview and Total Revenue
11.6.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Zoetis Prophylactic Human Vaccine Products Offered
11.6.5 Zoetis Recent Development
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description, Business Overview and Total Revenue
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Prophylactic Human Vaccine Products Offered
11.7.5 Sanofi Recent Development
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description, Business Overview and Total Revenue
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Prophylactic Human Vaccine Products Offered
11.1.5 GSK Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Prophylactic Human Vaccine Market Estimates and Projections by Region
12.1.1 Global Prophylactic Human Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Prophylactic Human Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Prophylactic Human Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Prophylactic Human Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Prophylactic Human Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Prophylactic Human Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Prophylactic Human Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Prophylactic Human Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Prophylactic Human Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Prophylactic Human Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Prophylactic Human Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Prophylactic Human Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Prophylactic Human Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Prophylactic Human Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Prophylactic Human Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Prophylactic Human Vaccine Product Introduction
1.2 Market Segments
1.3 Key Prophylactic Human Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Prophylactic Human Vaccine Market Size Growth Rate by Type
1.4.2 Inactivated Vaccine
1.4.3 Attenuated Vaccine
1.4.4 Others
1.5 Market by Application
1.5.1 Global Prophylactic Human Vaccine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Scientific Research
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Prophylactic Human Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Prophylactic Human Vaccine Industry
1.6.1.1 Prophylactic Human Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Prophylactic Human Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Prophylactic Human Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Prophylactic Human Vaccine Market Size Estimates and Forecasts
2.1.1 Global Prophylactic Human Vaccine Revenue 2015-2026
2.1.2 Global Prophylactic Human Vaccine Sales 2015-2026
2.2 Prophylactic Human Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Prophylactic Human Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Prophylactic Human Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PROPHYLACTIC HUMAN VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Prophylactic Human Vaccine Sales by Manufacturers
3.1.1 Prophylactic Human Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Prophylactic Human Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Prophylactic Human Vaccine Revenue by Manufacturers
3.2.1 Prophylactic Human Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Prophylactic Human Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Prophylactic Human Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Prophylactic Human Vaccine Revenue in 2019
3.2.5 Global Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Prophylactic Human Vaccine Price by Manufacturers
3.4 Prophylactic Human Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Prophylactic Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prophylactic Human Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Prophylactic Human Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Prophylactic Human Vaccine Market Size by Type (2015-2020)
4.1.1 Global Prophylactic Human Vaccine Sales by Type (2015-2020)
4.1.2 Global Prophylactic Human Vaccine Revenue by Type (2015-2020)
4.1.3 Prophylactic Human Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Prophylactic Human Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Prophylactic Human Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Prophylactic Human Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Prophylactic Human Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Prophylactic Human Vaccine Market Size by Application (2015-2020)
5.1.1 Global Prophylactic Human Vaccine Sales by Application (2015-2020)
5.1.2 Global Prophylactic Human Vaccine Revenue by Application (2015-2020)
5.1.3 Prophylactic Human Vaccine Price by Application (2015-2020)
5.2 Prophylactic Human Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Prophylactic Human Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Prophylactic Human Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Prophylactic Human Vaccine by Country
6.1.1 North America Prophylactic Human Vaccine Sales by Country
6.1.2 North America Prophylactic Human Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Prophylactic Human Vaccine Market Facts & Figures by Type
6.3 North America Prophylactic Human Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Prophylactic Human Vaccine by Country
7.1.1 Europe Prophylactic Human Vaccine Sales by Country
7.1.2 Europe Prophylactic Human Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Prophylactic Human Vaccine Market Facts & Figures by Type
7.3 Europe Prophylactic Human Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Prophylactic Human Vaccine by Region
8.1.1 Asia Pacific Prophylactic Human Vaccine Sales by Region
8.1.2 Asia Pacific Prophylactic Human Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Prophylactic Human Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Prophylactic Human Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Prophylactic Human Vaccine by Country
9.1.1 Latin America Prophylactic Human Vaccine Sales by Country
9.1.2 Latin America Prophylactic Human Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Prophylactic Human Vaccine Market Facts & Figures by Type
9.3 Central & South America Prophylactic Human Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Prophylactic Human Vaccine by Country
10.1.1 Middle East and Africa Prophylactic Human Vaccine Sales by Country
10.1.2 Middle East and Africa Prophylactic Human Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Prophylactic Human Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Prophylactic Human Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description, Business Overview and Total Revenue
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Prophylactic Human Vaccine Products Offered
11.1.5 GSK Recent Development
11.2 Biovac
11.2.1 Biovac Corporation Information
11.2.2 Biovac Description, Business Overview and Total Revenue
11.2.3 Biovac Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biovac Prophylactic Human Vaccine Products Offered
11.2.5 Biovac Recent Development
11.3 McKesson Medical
11.3.1 McKesson Medical Corporation Information
11.3.2 McKesson Medical Description, Business Overview and Total Revenue
11.3.3 McKesson Medical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 McKesson Medical Prophylactic Human Vaccine Products Offered
11.3.5 McKesson Medical Recent Development
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description, Business Overview and Total Revenue
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Prophylactic Human Vaccine Products Offered
11.4.5 Merck Recent Development
11.5 Merial
11.5.1 Merial Corporation Information
11.5.2 Merial Description, Business Overview and Total Revenue
11.5.3 Merial Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merial Prophylactic Human Vaccine Products Offered
11.5.5 Merial Recent Development
11.6 Zoetis
11.6.1 Zoetis Corporation Information
11.6.2 Zoetis Description, Business Overview and Total Revenue
11.6.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Zoetis Prophylactic Human Vaccine Products Offered
11.6.5 Zoetis Recent Development
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description, Business Overview and Total Revenue
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Prophylactic Human Vaccine Products Offered
11.7.5 Sanofi Recent Development
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description, Business Overview and Total Revenue
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Prophylactic Human Vaccine Products Offered
11.1.5 GSK Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Prophylactic Human Vaccine Market Estimates and Projections by Region
12.1.1 Global Prophylactic Human Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Prophylactic Human Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Prophylactic Human Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Prophylactic Human Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Prophylactic Human Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Prophylactic Human Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Prophylactic Human Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Prophylactic Human Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Prophylactic Human Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Prophylactic Human Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Prophylactic Human Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Prophylactic Human Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Prophylactic Human Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Prophylactic Human Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Prophylactic Human Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Prophylactic Human Vaccine Market Segments
Table 2. Ranking of Global Top Prophylactic Human Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Prophylactic Human Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Inactivated Vaccine
Table 5. Major Manufacturers of Attenuated Vaccine
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Prophylactic Human Vaccine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Prophylactic Human Vaccine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Prophylactic Human Vaccine Players to Combat Covid-19 Impact
Table 12. Global Prophylactic Human Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Prophylactic Human Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Prophylactic Human Vaccine Sales by Regions 2015-2020 (K Units)
Table 15. Global Prophylactic Human Vaccine Sales Market Share by Regions (2015-2020)
Table 16. Global Prophylactic Human Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Prophylactic Human Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Prophylactic Human Vaccine Sales Share by Manufacturers (2015-2020)
Table 19. Global Prophylactic Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Prophylactic Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic Human Vaccine as of 2019)
Table 21. Prophylactic Human Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Prophylactic Human Vaccine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Prophylactic Human Vaccine Price (2015-2020) (USD/Unit)
Table 24. Prophylactic Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Prophylactic Human Vaccine Product Type
Table 26. Date of International Manufacturers Enter into Prophylactic Human Vaccine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 29. Global Prophylactic Human Vaccine Sales Share by Type (2015-2020)
Table 30. Global Prophylactic Human Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Prophylactic Human Vaccine Revenue Share by Type (2015-2020)
Table 32. Prophylactic Human Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 34. Global Prophylactic Human Vaccine Sales Share by Application (2015-2020)
Table 35. North America Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units)
Table 36. North America Prophylactic Human Vaccine Sales Market Share by Country (2015-2020)
Table 37. North America Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020)
Table 39. North America Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 40. North America Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 41. North America Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 42. North America Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 43. Europe Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units)
Table 44. Europe Prophylactic Human Vaccine Sales Market Share by Country (2015-2020)
Table 45. Europe Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020)
Table 47. Europe Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 48. Europe Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 50. Europe Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Prophylactic Human Vaccine Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Prophylactic Human Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Prophylactic Human Vaccine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 59. Latin America Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units)
Table 60. Latin America Prophylactic Human Vaccine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 64. Latin America Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 65. Latin America Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 66. Latin America Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 75. GSK Corporation Information
Table 76. GSK Description and Major Businesses
Table 77. GSK Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. GSK Product
Table 79. GSK Recent Development
Table 80. Biovac Corporation Information
Table 81. Biovac Description and Major Businesses
Table 82. Biovac Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Biovac Product
Table 84. Biovac Recent Development
Table 85. McKesson Medical Corporation Information
Table 86. McKesson Medical Description and Major Businesses
Table 87. McKesson Medical Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. McKesson Medical Product
Table 89. McKesson Medical Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Major Businesses
Table 92. Merck Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Merck Product
Table 94. Merck Recent Development
Table 95. Merial Corporation Information
Table 96. Merial Description and Major Businesses
Table 97. Merial Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merial Product
Table 99. Merial Recent Development
Table 100. Zoetis Corporation Information
Table 101. Zoetis Description and Major Businesses
Table 102. Zoetis Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Zoetis Product
Table 104. Zoetis Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Sanofi Product
Table 109. Sanofi Recent Development
Table 110. Global Prophylactic Human Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 111. Global Prophylactic Human Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 112. Global Prophylactic Human Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 113. Global Prophylactic Human Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 114. North America: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 115. North America: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Europe: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 117. Europe: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Asia Pacific: Prophylactic Human Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 119. Asia Pacific: Prophylactic Human Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 120. Latin America: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 121. Latin America: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Middle East and Africa: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 123. Middle East and Africa: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Prophylactic Human Vaccine Players
Table 128. Prophylactic Human Vaccine Customers List
Table 129. Prophylactic Human Vaccine Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 1. Prophylactic Human Vaccine Market Segments
Table 2. Ranking of Global Top Prophylactic Human Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Prophylactic Human Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Inactivated Vaccine
Table 5. Major Manufacturers of Attenuated Vaccine
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Prophylactic Human Vaccine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Prophylactic Human Vaccine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Prophylactic Human Vaccine Players to Combat Covid-19 Impact
Table 12. Global Prophylactic Human Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Prophylactic Human Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Prophylactic Human Vaccine Sales by Regions 2015-2020 (K Units)
Table 15. Global Prophylactic Human Vaccine Sales Market Share by Regions (2015-2020)
Table 16. Global Prophylactic Human Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Prophylactic Human Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Prophylactic Human Vaccine Sales Share by Manufacturers (2015-2020)
Table 19. Global Prophylactic Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Prophylactic Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic Human Vaccine as of 2019)
Table 21. Prophylactic Human Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Prophylactic Human Vaccine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Prophylactic Human Vaccine Price (2015-2020) (USD/Unit)
Table 24. Prophylactic Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Prophylactic Human Vaccine Product Type
Table 26. Date of International Manufacturers Enter into Prophylactic Human Vaccine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 29. Global Prophylactic Human Vaccine Sales Share by Type (2015-2020)
Table 30. Global Prophylactic Human Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Prophylactic Human Vaccine Revenue Share by Type (2015-2020)
Table 32. Prophylactic Human Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 34. Global Prophylactic Human Vaccine Sales Share by Application (2015-2020)
Table 35. North America Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units)
Table 36. North America Prophylactic Human Vaccine Sales Market Share by Country (2015-2020)
Table 37. North America Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020)
Table 39. North America Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 40. North America Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 41. North America Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 42. North America Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 43. Europe Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units)
Table 44. Europe Prophylactic Human Vaccine Sales Market Share by Country (2015-2020)
Table 45. Europe Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020)
Table 47. Europe Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 48. Europe Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 50. Europe Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Prophylactic Human Vaccine Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Prophylactic Human Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Prophylactic Human Vaccine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 59. Latin America Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units)
Table 60. Latin America Prophylactic Human Vaccine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 64. Latin America Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 65. Latin America Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 66. Latin America Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 75. GSK Corporation Information
Table 76. GSK Description and Major Businesses
Table 77. GSK Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. GSK Product
Table 79. GSK Recent Development
Table 80. Biovac Corporation Information
Table 81. Biovac Description and Major Businesses
Table 82. Biovac Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Biovac Product
Table 84. Biovac Recent Development
Table 85. McKesson Medical Corporation Information
Table 86. McKesson Medical Description and Major Businesses
Table 87. McKesson Medical Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. McKesson Medical Product
Table 89. McKesson Medical Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Major Businesses
Table 92. Merck Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Merck Product
Table 94. Merck Recent Development
Table 95. Merial Corporation Information
Table 96. Merial Description and Major Businesses
Table 97. Merial Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merial Product
Table 99. Merial Recent Development
Table 100. Zoetis Corporation Information
Table 101. Zoetis Description and Major Businesses
Table 102. Zoetis Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Zoetis Product
Table 104. Zoetis Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Sanofi Product
Table 109. Sanofi Recent Development
Table 110. Global Prophylactic Human Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 111. Global Prophylactic Human Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 112. Global Prophylactic Human Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 113. Global Prophylactic Human Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 114. North America: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 115. North America: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Europe: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 117. Europe: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Asia Pacific: Prophylactic Human Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 119. Asia Pacific: Prophylactic Human Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 120. Latin America: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 121. Latin America: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Middle East and Africa: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 123. Middle East and Africa: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Prophylactic Human Vaccine Players
Table 128. Prophylactic Human Vaccine Customers List
Table 129. Prophylactic Human Vaccine Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Prophylactic Human Vaccine Product Picture
Figure 2. Global Prophylactic Human Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Attenuated Vaccine Product Picture
Figure 5. Others Product Picture
Figure 6. Global Prophylactic Human Vaccine Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Scientific Research
Figure 9. Others
Figure 10. Prophylactic Human Vaccine Report Years Considered
Figure 11. Global Prophylactic Human Vaccine Market Size 2015-2026 (US$ Million)
Figure 12. Global Prophylactic Human Vaccine Sales 2015-2026 (K Units)
Figure 13. Global Prophylactic Human Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Prophylactic Human Vaccine Sales Market Share by Region (2015-2020)
Figure 15. Global Prophylactic Human Vaccine Sales Market Share by Region in 2019
Figure 16. Global Prophylactic Human Vaccine Revenue Market Share by Region (2015-2020)
Figure 17. Global Prophylactic Human Vaccine Revenue Market Share by Region in 2019
Figure 18. Global Prophylactic Human Vaccine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Prophylactic Human Vaccine Revenue in 2019
Figure 20. Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Figure 22. Global Prophylactic Human Vaccine Sales Market Share by Type in 2019
Figure 23. Global Prophylactic Human Vaccine Revenue Market Share by Type (2015-2020)
Figure 24. Global Prophylactic Human Vaccine Revenue Market Share by Type in 2019
Figure 25. Global Prophylactic Human Vaccine Market Share by Price Range (2015-2020)
Figure 26. Global Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Figure 27. Global Prophylactic Human Vaccine Sales Market Share by Application in 2019
Figure 28. Global Prophylactic Human Vaccine Revenue Market Share by Application (2015-2020)
Figure 29. Global Prophylactic Human Vaccine Revenue Market Share by Application in 2019
Figure 30. North America Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Prophylactic Human Vaccine Sales Market Share by Country in 2019
Figure 33. North America Prophylactic Human Vaccine Revenue Market Share by Country in 2019
Figure 34. U.S. Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Prophylactic Human Vaccine Market Share by Type in 2019
Figure 39. North America Prophylactic Human Vaccine Market Share by Application in 2019
Figure 40. Europe Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Prophylactic Human Vaccine Sales Market Share by Country in 2019
Figure 43. Europe Prophylactic Human Vaccine Revenue Market Share by Country in 2019
Figure 44. Germany Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Prophylactic Human Vaccine Market Share by Type in 2019
Figure 55. Europe Prophylactic Human Vaccine Market Share by Application in 2019
Figure 56. Asia Pacific Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Prophylactic Human Vaccine Revenue Market Share by Region in 2019
Figure 60. China Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Prophylactic Human Vaccine Market Share by Type in 2019
Figure 83. Asia Pacific Prophylactic Human Vaccine Market Share by Application in 2019
Figure 84. Latin America Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Prophylactic Human Vaccine Sales Market Share by Country in 2019
Figure 87. Latin America Prophylactic Human Vaccine Revenue Market Share by Country in 2019
Figure 88. Mexico Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Prophylactic Human Vaccine Market Share by Type in 2019
Figure 95. Latin America Prophylactic Human Vaccine Market Share by Application in 2019
Figure 96. Middle East and Africa Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Prophylactic Human Vaccine Revenue Market Share by Country in 2019
Figure 100. Turkey Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Prophylactic Human Vaccine Market Share by Type in 2019
Figure 107. Middle East and Africa Prophylactic Human Vaccine Market Share by Application in 2019
Figure 108. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Biovac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. McKesson Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Merial Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. North America Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Europe Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Asia Pacific Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Latin America Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Middle East and Africa Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
Figure 1. Prophylactic Human Vaccine Product Picture
Figure 2. Global Prophylactic Human Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Attenuated Vaccine Product Picture
Figure 5. Others Product Picture
Figure 6. Global Prophylactic Human Vaccine Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Scientific Research
Figure 9. Others
Figure 10. Prophylactic Human Vaccine Report Years Considered
Figure 11. Global Prophylactic Human Vaccine Market Size 2015-2026 (US$ Million)
Figure 12. Global Prophylactic Human Vaccine Sales 2015-2026 (K Units)
Figure 13. Global Prophylactic Human Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Prophylactic Human Vaccine Sales Market Share by Region (2015-2020)
Figure 15. Global Prophylactic Human Vaccine Sales Market Share by Region in 2019
Figure 16. Global Prophylactic Human Vaccine Revenue Market Share by Region (2015-2020)
Figure 17. Global Prophylactic Human Vaccine Revenue Market Share by Region in 2019
Figure 18. Global Prophylactic Human Vaccine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Prophylactic Human Vaccine Revenue in 2019
Figure 20. Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Figure 22. Global Prophylactic Human Vaccine Sales Market Share by Type in 2019
Figure 23. Global Prophylactic Human Vaccine Revenue Market Share by Type (2015-2020)
Figure 24. Global Prophylactic Human Vaccine Revenue Market Share by Type in 2019
Figure 25. Global Prophylactic Human Vaccine Market Share by Price Range (2015-2020)
Figure 26. Global Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Figure 27. Global Prophylactic Human Vaccine Sales Market Share by Application in 2019
Figure 28. Global Prophylactic Human Vaccine Revenue Market Share by Application (2015-2020)
Figure 29. Global Prophylactic Human Vaccine Revenue Market Share by Application in 2019
Figure 30. North America Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Prophylactic Human Vaccine Sales Market Share by Country in 2019
Figure 33. North America Prophylactic Human Vaccine Revenue Market Share by Country in 2019
Figure 34. U.S. Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Prophylactic Human Vaccine Market Share by Type in 2019
Figure 39. North America Prophylactic Human Vaccine Market Share by Application in 2019
Figure 40. Europe Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Prophylactic Human Vaccine Sales Market Share by Country in 2019
Figure 43. Europe Prophylactic Human Vaccine Revenue Market Share by Country in 2019
Figure 44. Germany Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Prophylactic Human Vaccine Market Share by Type in 2019
Figure 55. Europe Prophylactic Human Vaccine Market Share by Application in 2019
Figure 56. Asia Pacific Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Prophylactic Human Vaccine Revenue Market Share by Region in 2019
Figure 60. China Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Prophylactic Human Vaccine Market Share by Type in 2019
Figure 83. Asia Pacific Prophylactic Human Vaccine Market Share by Application in 2019
Figure 84. Latin America Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Prophylactic Human Vaccine Sales Market Share by Country in 2019
Figure 87. Latin America Prophylactic Human Vaccine Revenue Market Share by Country in 2019
Figure 88. Mexico Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Prophylactic Human Vaccine Market Share by Type in 2019
Figure 95. Latin America Prophylactic Human Vaccine Market Share by Application in 2019
Figure 96. Middle East and Africa Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Prophylactic Human Vaccine Revenue Market Share by Country in 2019
Figure 100. Turkey Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Prophylactic Human Vaccine Market Share by Type in 2019
Figure 107. Middle East and Africa Prophylactic Human Vaccine Market Share by Application in 2019
Figure 108. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Biovac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. McKesson Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Merial Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. North America Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Europe Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Asia Pacific Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Latin America Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Middle East and Africa Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
